Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Datos Bibliográficos
| ID | 14907700 |
|---|---|
| Autores | Phillip Read (0000-0001-5422-3777, UNSW Sydney, autor de correspondencia), Rebecca Lothian (South Eastern Sydney Local Health District), Karen J Chronister (0000-0002-8448-5572, South Eastern Sydney Local Health District), Karen Chronister, Rosie Gilliver (South Eastern Sydney Local Health District), John Kearley (South Eastern Sydney Local Health District), Gregory J Dore (0000-0002-4741-2622, St Vincent's Hospital Sydney), Ingrid van Beek (UNSW Sydney) |
| Año | 2017 |
| Volumen | 47 |
| Páginas | 209-215 |
| Fecha de publicación | 2017-09-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Drug Policy (JOURNAL) |
| Identificadores de la revista | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2017.05.032 |
| PMID | 28587943 |
| OpenAlex | W2620881498 |
| Idioma | EN |
| Citas recibidas | 33 |
| Referencias citadas | 17 |
Adverse effect · Family medicine · Hepatitis C · Hepatitis B Virus Studies · Hepatitis C virus research · Liver Disease Diagnosis and Treatment · Medicine · Internal Medicine
Reasons for Not Seeking Hepatitis C Treatment among People Who Inject Drugs
Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration
Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
Retracted Article
Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings
Geographical analysis of evaluated chronic disease programs for Aboriginal and Torres Strait Islander people in the Australian primary health care setting
Outcomes of a tertiary-based innovative approach to engage primary care providers in provision of hepatitis C treatment in community settings
Factors associated with lost to follow-up after hepatitis C treatment delivered by primary care teams in an inner-city multi-site program, Vancouver, Canada
Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia
Making sense of ‘side effects’
Everybody living with a chronic disease is entitled to be cured”
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic
Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs
Elimination of hepatitis C virus infection among PWID
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene
Community-Based Assessment and Treatment of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst People Who Are Homeless
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals
A hepatitis C elimination model in healthcare for the homeless organization
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs
Initiating HCV treatment with direct acting agents in opioid agonist treatment
Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia
Understanding real-world adherence in the directly acting antiviral era
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Transitioning from interferon-based to direct antiviral treatment options
Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1–6 receiving opioid substitution therapy
Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use
Integrated models of care for people who inject drugs and live with hepatitis C virus
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era
Hepatitis C virus treatment for prevention among people who inject drugs
The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs
Understanding real-world adherence in the directly acting antiviral era
Case study
Housing Instability among People Who Inject Drugs
| Obras citantes distintas | 33 |
|---|---|
| Citas por año | 3,67 |
| Intervalo de citas | 2017 - 2023 (7) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 33 |